Us Developing Vaccine
- All
- News
- Videos
-
Trump Administration To Cut Vaccine Support To Developing Countries: Report
President Donald Trump's administration is set to cut funding to Gavi, the global health organization that provides vaccines across the developing world, a report said.
-
"Wish I Hadn't": US Anchor Megyn Kelly's Big Claim On Pfizer Covid Vaccine
American journalist Megyn Kelly has claimed that she developed an "autoimmune condition" after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021.
-
All About Katalin Kariko And Drew Weissman, Nobel Medicine Prize Winners
Hungary's Katalin Kariko and US' Drew Weissman on Monday won the Nobel Prize in Medicine for their discoveries that were critical for developing effective mRNA vaccines against COVID-19.
-
Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
-
US Delays Approval For Moderna Covid Vaccine In Teenagers
US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis, or heart inflammation.
-
US To Finance India's Biological E In $50 Million Covid Vaccine Deal
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
New 3D Printed Vaccine Patch More Effective Than Traditional Jabs: US Study
Scientists have developed a three-dimensional (3D) printed vaccine patch thatis not just less painful and less invasive than a traditional vaccine, but also provides greater protection than a typical immunisation shot.
-
Over 56 Million Indians Benefited With Covid-Related Health Training: US
The US Agency for International Development (USAID) has reached more than 56 million Indians with COVID-related health training, risk mitigation and vaccine information, and essential equipment since the beginning of the pandemic, White House stateme
-
US Panel Recommends Pfizer Covid Boosters For Only Elderly, People At High Risk
A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.
-
S Jaishankar Meets US Lawmakers, Discusses Quad, Cooperation On Vaccines
External Affairs Minister S Jaishankar met influential American lawmakers from both the Democratic and Republican parties on Thursday and discussed developments pertaining to Quad and the cooperation on vaccines with them.
-
South Africa Pauses Johnson & Johnson Vaccine Use Over Blood Clot Risks
South Africa has joined the US in suspending its rollout of the Johnson & Johnson COVID-19 vaccine, following reports that six women who received the immunisation doses had developed unusual blood clots with low platelet count.
-
US Stops AstraZeneca Vaccine Production At Baltimore Plant: Report
The U.S. government on Saturday stopped a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson's COVID-19 vaccine from making the vaccine developed by AstraZeneca Plc, the New York Times reported.
-
Pfizer, Moderna Vaccines Highly Effective Even After 1st Shot: US Study
COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc reduced the risk of infection by 80 per cent two weeks or more after the first of two shots, according to data from a real-world study of vaccinated US healthcare personnel and first responders released on Monday.
-
US To Support India's Biological E In Covid Vaccine Development: Report
The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization (SRA) and/or WHO Emergency Use listing including Johnson & Johnson vaccines.
-
US Giant Merck Ends Covid Vaccine After Poor Response
Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.
-
Trump Administration To Cut Vaccine Support To Developing Countries: Report
President Donald Trump's administration is set to cut funding to Gavi, the global health organization that provides vaccines across the developing world, a report said.
-
"Wish I Hadn't": US Anchor Megyn Kelly's Big Claim On Pfizer Covid Vaccine
American journalist Megyn Kelly has claimed that she developed an "autoimmune condition" after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021.
-
All About Katalin Kariko And Drew Weissman, Nobel Medicine Prize Winners
Hungary's Katalin Kariko and US' Drew Weissman on Monday won the Nobel Prize in Medicine for their discoveries that were critical for developing effective mRNA vaccines against COVID-19.
-
Bharat Biotech's Covaxin Approval Requested In US For Children Below 18
US company Ocugen announced Friday that it had asked authorities for emergency use authorization for Covid-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.
-
US Delays Approval For Moderna Covid Vaccine In Teenagers
US biotech firm Moderna said Sunday that American officials have delayed approving its COVID-19 vaccine for teenagers to allow more time to better assess the potential risk of developing myocarditis, or heart inflammation.
-
US To Finance India's Biological E In $50 Million Covid Vaccine Deal
The United States and India's Biological E. Ltd said on Monday they had finalised a financing arrangement for $50 million to expand the vaccine maker's capacity to produce COVID-19 shots.
-
New 3D Printed Vaccine Patch More Effective Than Traditional Jabs: US Study
Scientists have developed a three-dimensional (3D) printed vaccine patch thatis not just less painful and less invasive than a traditional vaccine, but also provides greater protection than a typical immunisation shot.
-
Over 56 Million Indians Benefited With Covid-Related Health Training: US
The US Agency for International Development (USAID) has reached more than 56 million Indians with COVID-related health training, risk mitigation and vaccine information, and essential equipment since the beginning of the pandemic, White House stateme
-
US Panel Recommends Pfizer Covid Boosters For Only Elderly, People At High Risk
A panel of leading US medical experts advising the government voted in favor of authorizing boosters of Pfizer's coronavirus vaccine for everyone aged 65 and up, as well as people at high risk of developing severe Covid.
-
S Jaishankar Meets US Lawmakers, Discusses Quad, Cooperation On Vaccines
External Affairs Minister S Jaishankar met influential American lawmakers from both the Democratic and Republican parties on Thursday and discussed developments pertaining to Quad and the cooperation on vaccines with them.
-
South Africa Pauses Johnson & Johnson Vaccine Use Over Blood Clot Risks
South Africa has joined the US in suspending its rollout of the Johnson & Johnson COVID-19 vaccine, following reports that six women who received the immunisation doses had developed unusual blood clots with low platelet count.
-
US Stops AstraZeneca Vaccine Production At Baltimore Plant: Report
The U.S. government on Saturday stopped a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson's COVID-19 vaccine from making the vaccine developed by AstraZeneca Plc, the New York Times reported.
-
Pfizer, Moderna Vaccines Highly Effective Even After 1st Shot: US Study
COVID-19 vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc reduced the risk of infection by 80 per cent two weeks or more after the first of two shots, according to data from a real-world study of vaccinated US healthcare personnel and first responders released on Monday.
-
US To Support India's Biological E In Covid Vaccine Development: Report
The US International Development Finance Corporation (DFC) has announced it will support Indian manufacturer Biological E's efforts to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022 with stringent regulatory authorization (SRA) and/or WHO Emergency Use listing including Johnson & Johnson vaccines.
-
US Giant Merck Ends Covid Vaccine After Poor Response
Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.
